Sandra E. Peterson

780 total citations
9 papers, 567 citations indexed

About

Sandra E. Peterson is a scholar working on Genetics, Pharmacology and Molecular Biology. According to data from OpenAlex, Sandra E. Peterson has authored 9 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Sandra E. Peterson's work include Pharmacogenetics and Drug Metabolism (4 papers), Genomics and Rare Diseases (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Sandra E. Peterson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Genomics and Rare Diseases (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Sandra E. Peterson collaborates with scholars based in United States, Canada and Poland. Sandra E. Peterson's co-authors include Linnea M. Baudhuin, Alan R. Zinsmeister, Jennifer Jones, Joseph P. McConnell, William J. Sandborn, Karen Hanson, Brian G. Feagan, Scott Harmsen, Edward V. Loftus and Remo Panaccione and has published in prestigious journals such as Clinical Chemistry, Clinical Gastroenterology and Hepatology and Diseases of the Colon & Rectum.

In The Last Decade

Sandra E. Peterson

9 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra E. Peterson United States 6 371 275 170 137 85 9 567
Mari Thörn Sweden 9 181 0.5× 182 0.7× 82 0.5× 94 0.7× 64 0.8× 12 407
K. Dilger Germany 9 211 0.6× 219 0.8× 111 0.7× 61 0.4× 42 0.5× 9 425
Valentina Shakhnovich United States 12 63 0.2× 41 0.1× 148 0.9× 136 1.0× 141 1.7× 50 486
Sigrid Nelson Canada 9 338 0.9× 264 1.0× 164 1.0× 11 0.1× 7 0.1× 13 620
P. A. M. van Hees Netherlands 11 140 0.4× 94 0.3× 122 0.7× 29 0.2× 26 0.3× 13 346
Nastya Kassir United States 13 37 0.1× 72 0.3× 48 0.3× 55 0.4× 84 1.0× 46 400
Jeffrey G. Levine United States 11 203 0.5× 229 0.8× 974 5.7× 40 0.3× 19 0.2× 27 1.2k
Michel Zabalza Spain 9 171 0.5× 219 0.8× 264 1.6× 64 0.5× 6 0.1× 23 694
Liat Mlynarsky Israel 9 102 0.3× 279 1.0× 67 0.4× 27 0.2× 5 0.1× 13 433

Countries citing papers authored by Sandra E. Peterson

Since Specialization
Citations

This map shows the geographic impact of Sandra E. Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra E. Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra E. Peterson more than expected).

Fields of papers citing papers by Sandra E. Peterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra E. Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra E. Peterson. The network helps show where Sandra E. Peterson may publish in the future.

Co-authorship network of co-authors of Sandra E. Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra E. Peterson. A scholar is included among the top collaborators of Sandra E. Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra E. Peterson. Sandra E. Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Choate, Lauren A., Adam J. Guenzel, Jessica Newman, et al.. (2023). Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation Sequencing. Clinical Chemistry. 69(10). 1155–1162. 2 indexed citations
2.
Peterson, Sandra E., et al.. (2023). Determination of the Duplicated CYP2D6 Allele Using Real-Time PCR Signal: An Alternative Approach. Journal of Personalized Medicine. 13(6). 883–883. 3 indexed citations
3.
Peterson, Sandra E., Katrina E. Kotzer, Guilherme S. Lopes, et al.. (2022). Targeted Genotyping in Clinical Pharmacogenomics. Journal of Molecular Diagnostics. 24(3). 253–261. 22 indexed citations
4.
Willrich, Maria Alice V., Erin Kaleta, Sandra C. Bryant, et al.. (2017). Genetic Variation in Statin Intolerance and a Possible Protective Role for UGT1A1. Pharmacogenomics. 19(2). 83–94. 10 indexed citations
5.
Ji, Yuan, Jennifer M. Skierka, Joseph H. Blommel, et al.. (2016). Preemptive Pharmacogenomic Testing for Precision Medicine. Journal of Molecular Diagnostics. 18(3). 438–445. 155 indexed citations
6.
Moore, Sarah E., Kimberlyn McGrail, Sandra E. Peterson, et al.. (2013). Infliximab in Ulcerative Colitis. Diseases of the Colon & Rectum. 57(1). 83–90. 33 indexed citations
7.
Skierka, Jennifer M., Denise L. Walker, Sandra E. Peterson, Dennis J. O’Kane, & John L. Black. (2012). CYP2D6*11 and Challenges in Clinical Genotyping of the Highly Polymorphic CYP2D6 Gene. Pharmacogenomics. 13(8). 951–954. 5 indexed citations
8.
Jones, Jennifer, Li-Sheng Chen, Linnea M. Baudhuin, et al.. (2008). Relationships between C-reactive protein concentration and genotype in healthy volunteers. Clinical Chemistry and Laboratory Medicine (CCLM). 47(1). 20–5. 11 indexed citations
9.
Jones, Jennifer, Edward V. Loftus, Remo Panaccione, et al.. (2008). Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology. 6(11). 1218–1224. 326 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026